Analyst firms · William Blair · ARGX

William Blair ARGX price target and rating history

argenx SE (ARGX) · Health Care

William Blair rates argenx SE (ARGX) Outperform, as of its latest action on Nov 1, 2024. It has published 3 rating actions on ARGX since December 2022, including 1 upgrade and 1 downgrade. Across 3 firms with a ARGX price target in the last 12 months, the median target is $1,185.

Current rating
Outperform
Price target
Not stated
Median target, all firms
$1,185
Actions on ARGX
3

Every William Blair rating on ARGX

How other firms rate ARGX

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
UBSBuy$1,400Aug 26, 2026
Deutsche BankHoldAug 24, 2026
GuggenheimBuy$1,185Aug 4, 2026
Robert W. BairdNeutral$858Dec 18, 2025
Wolfe ResearchPeer PerformNov 24, 2025

Questions about William Blair and ARGX

What is William Blair's rating on ARGX?
William Blair rates ARGX Outperform, a bullish rating, as of Nov 1, 2024.
When did William Blair last change its view on ARGX?
On Nov 1, 2024, William Blair upgrades to Outperform from Mkt Perform.
How does William Blair's ARGX target compare with other analysts?
Across 3 firms with a ARGX price target in the last 12 months, the median target is $1,185.

More ARGX rating histories

All William Blair ratingsARGX news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.